WF - PGEN: Publication Highlights Need for Multi Antigen Targeting for Elimination of Recurrent Res | PGEN Message Board Posts


PGEN   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  50975 of 51263  at  8/12/2022 4:42:44 PM  by

Mabel


 In response to msg 50958 by  Redwood1205
view thread

Re: WF - PGEN: Publication Highlights Need for Multi Antigen Targeting for Elimination of Recurrent Respiratory Papillomatosis (Overweight PT 17)

I repeat that 2012 will be approved before your bull case and years before your base case. The recent clinical trials update for AML posts primary completion by year end. You are the one speculating.”
 
and Heart was going to be commercialized in 2020.  You are so out of your depth it is embarrassing.  
You said we were going to get data on 2012 during August’s earnings… where was it? 
I said we would not see a data readout on the 15 phase 1 patients until November at this earliest.  You should have sent me a DM to understand my reasoning like others did. Although I might have not responded.  


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 2  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
50976 Re: WF - PGEN: Publication Highlights Need for Multi Antigen Targeting for Elimination of Recurrent Respiratory Papillomatosis (Overweight PT 17) Redwood1205 0 8/12/2022 5:26:56 PM




Financial Market Data provided by
.
Loading...